Ajax-Loading

AstraZeneca PLC - Cash and Short Term Investments

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-and-Short-Term-Investments" stands at 8.18 Billion United States Dollars as of 09/30/2025, the highest value since 09/30/2021.

As of the end of AstraZeneca PLC's third quarter, the item "Cash and Short Term Investments" stands at 8.18 Billion USD. This represents an increase of 15.02 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 66.34 percent compared to the value the year prior.
The 1 year change in percent is 66.34.
The 3 year change in percent is 68.55.
The 5 year change in percent is -2.96.
The 10 year change in percent is 78.76.

The Serie's long term average value is 6.67 Billion United States Dollars. It's latest available value, on 09/30/2025, is 22.61 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2017, to it's latest available value, on 09/30/2025, is +123.31%.
The Serie's change in percent from it's maximum value, on 06/30/2021, to it's latest available value, on 09/30/2025, is -47.66%.

Cash and Short Term Investments for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash and Short Term Investments905,699,262,464.00
LogoJohnson & Johnson - Cash and Short Term Investments486,508,953,600.00
LogoAbbVie Inc - Cash and Short Term Investments399,570,305,024.00
LogoRoche Holding AG - Cash and Short Term Investments317,433,206,677.55
LogoNovartis AG - Cash and Short Term Investments255,096,620,580.91